Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L3RN
|
|||
| Drug Name |
Epoxysuccinate derivative 5
|
|||
| Synonyms |
PMID25399719-Compound-22
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Calpain-2 (CAPN2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Calpain-2 (CAPN2) | Target's Patent Info | [1] | |
| KEGG Pathway | Protein processing in endoplasmic reticulum | |||
| Apoptosis | ||||
| Alzheimer's disease | ||||
| Reactome | Degradation of the extracellular matrix | |||
| WikiPathways | Focal Adhesion | |||
| Integrated Pancreatic Cancer Pathway | ||||
| Alzheimers Disease | ||||
| Integrin-mediated Cell Adhesion | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.